-
公开(公告)号:US4738967A
公开(公告)日:1988-04-19
申请号:US945788
申请日:1986-12-23
IPC分类号: C07D471/04 , A61K31/47 , A61P1/04 , C07D487/04 , A61K31/40
CPC分类号: C07D487/04
摘要: A compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl,R.sup.3 is hydrogen, halogen or ar(lower)alkoxy, andR is lower alkanoyl, nitroso, amino, carboxy, esterified carboxy, carbamoyl, hydroxycarbamoyl, haloformyl, aminomethyleneamino which may be substituted with cyano or lower alkyl, iminomethylamino which may be substituted with cyano or lower alkyl, or a group of the formula: --A--R.sup.2 in which A is lower alkylene andR.sup.2 is di(lower) alkylamino, cyano, lower alkoxy, N-containing heterocyclic group which may have suitable substituent(s), lower alkynyloxy, lower alkenyloxy, lower alkylthio, amino(lower)alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, carboxy, esterified carboxy, carbamoyl, hydroxycarbamoyl, hydroxy, lower alkanoyloxy, heterocyclicamino(lower)alkylthio having two oxo groups, hydrogen or a group of the formula: ##STR2## in which R.sup.4, R.sup.5 and R.sup.6 are each lower alkyl andX is an acid residue,and pharmaceutically acceptable salts thereof. pa The compounds are useful as anti ulcer agents.
-
公开(公告)号:US4686227A
公开(公告)日:1987-08-11
申请号:US745638
申请日:1985-06-17
IPC分类号: C07D471/04 , A61K31/47 , A61P1/04 , C07D487/04 , A61K31/395 , C07D405/04
CPC分类号: C07D487/04
摘要: A compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl,R.sup.3 is hydrogen, halogen or ar(lower)alkoxy, andR is lower alkanoyl, nitroso, amino, carboxy, esterified carboxy, carbamoyl, hydroxycarbamoyl, haloformyl, aminomethyleneamino which may be substituted with cyano or lower alkyl, iminomethylamino which may be substituted with cyano or lower alkyl, or a group of the formula: --A--R.sup.2 in whichA is lower alkylene andR.sup.2 is di(lower)alkylamino, cyano, lower alkoxy, N-containing heterocyclic group which may have suitable substituent(s), lower alkynyloxy, lower alkenyloxy, lower alkylthio, amino(lower)alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, carboxy, esterified carboxy, carbamoyl, hydroxycarbamoyl, hydroxy, lower alkanoyloxy, heterocyclicamino (lower)alkylthio having two oxo groups, hydrogen or a group of the formula: ##STR2## in which R.sup.4, R.sup.5 and R.sup.6 are each lower alkyl andX is an acid residue,and pharmaceutically acceptable salts thereof.The compounds are useful as anti ulcer agents.
摘要翻译: 下式的化合物,其中R 1为低级烷基,R 3为氢,卤素或芳(低级)烷氧基,R为低级烷酰基,亚硝基,氨基,羧基,酯化羧基,氨基甲酰基,羟基氨基甲酰基,卤代甲酰基,氨基亚甲基氨基 可以被氰基或低级烷基取代,可以被氰基或低级烷基取代的亚氨基甲基氨基,或下列基团:其中A是低级亚烷基,R2是二(低级)烷基氨基,氰基,低级烷氧基 ,可具有适当取代基的含N杂环基,低级炔氧基,低级烯氧基,低级烷硫基,氨基(低级)烷硫基,低级烷基亚磺酰基,低级烷基磺酰基,羧基,酯化羧基,氨基甲酰基,羟基氨基甲酰基,羟基,低级烷酰氧基, 具有两个氧代基的杂环氨基(低级)烷硫基,氢或下式的基团:其中R 4,R 5和R 6各自为低级烷基,X为酸残基,及其药学上可接受的盐。 该化合物可用作抗溃疡剂。
-
3.
公开(公告)号:US5234930A
公开(公告)日:1993-08-10
申请号:US866215
申请日:1992-04-09
IPC分类号: A61K31/435 , A61K31/437 , A61K31/445 , A61K31/4545 , A61P3/04 , A61P3/06 , A61P7/02 , A61P7/10 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/08 , A61P13/02 , A61P15/00 , A61P19/06 , A61P25/04 , A61P25/24 , A61P25/26 , A61P25/28 , A61P37/06 , C07D221/00 , C07D231/00 , C07D471/04
CPC分类号: C07D471/04
摘要: This invention relates to pyrazolopyridine compounds for the treatment of melancholia, heart failure, hypertension, renal insufficiency, renal toxicity, nephrosis, nephritis, edema, obesity, bronchial asthma, gout, hyperuricemia, sudden infant death syndrome, immunosuppression, diabetes, myocardial infarction, thrombosis, obstruction, arteriosclerosis obliterans, thrombophlebitis, cerebral infarction, transient ischemic attack or angina pectoris, said compounds being of the formula ##STR1## wherein the radicals are defined in the claims.
-
公开(公告)号:US5296490A
公开(公告)日:1994-03-22
申请号:US968664
申请日:1992-10-30
IPC分类号: A61K31/435 , A61P7/02 , A61P7/10 , A61P9/04 , A61P9/12 , A61P13/02 , A61P15/00 , C07D471/04
CPC分类号: C07D471/04
摘要: The disclosure concerns pyrazolopyridine compounds of the formulawherein the variables are defined in the specification. The compounds are useful as a diuretic, anti-hypertensive agent, etc.
摘要翻译: 本公开涉及下式的吡唑并吡啶化合物,其中变量在说明书中定义。 该化合物可用作利尿剂,抗高血压剂等。
-
公开(公告)号:US4925849A
公开(公告)日:1990-05-15
申请号:US202526
申请日:1988-06-06
IPC分类号: A61K31/435 , A61P7/02 , A61P7/10 , A61P9/04 , A61P9/12 , A61P13/02 , A61P15/00 , C07D471/04
CPC分类号: C07D471/04
摘要: The disclosure deals with a pyrazolopyridine compound of the formula ##STR1## wherein the variables are defined in the specification. The compounds are useful as a diuretic, antihypertensive agent, etc.
-
公开(公告)号:US5155114A
公开(公告)日:1992-10-13
申请号:US715460
申请日:1991-06-14
IPC分类号: C07D471/04 , C07D519/00
CPC分类号: C07D471/04
摘要: The invention relates to a method for the prevention and/or treatment of renal toxicity, nephrosis or nephritis, which comprises administering a pyrazolopyridine compound of the formula: ##STR1## wherein R.sup.1 is aryl, andR.sup.2 is unsaturated heterocyclic group which contains at least one heteroatom selected from the group consisting of N, O and S, which may have one or more suitable substituent(s), or a pharmaceutically acceptable salt thereof to a human being or an animal.
摘要翻译: 本发明涉及一种用于预防和/或治疗肾毒性,肾病或肾炎的方法,其包括施用下式的吡唑并吡啶化合物:其中R1是芳基,R2是不饱和杂环基,其含有至少一个 选自N,O和S的杂原子,其可以具有一个或多个合适的取代基或其药学上可接受的盐给人或动物。
-
公开(公告)号:US4985444A
公开(公告)日:1991-01-15
申请号:US466929
申请日:1990-01-18
IPC分类号: A61K31/435 , A61K31/437 , A61K31/44 , A61K31/50 , A61K31/505 , A61P3/06 , A61P7/02 , A61P7/10 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/12 , A61P11/00 , A61P11/08 , A61P13/02 , A61P15/00 , A61P19/00 , A61P25/04 , A61P25/24 , A61P25/26 , A61P29/00 , A61P43/00 , C07D471/04 , C07D513/04 , C07D519/00 , C07D521/00
CPC分类号: C07D471/04
摘要: The invention relates to pyrazolopyridine compounds for the treatment of melancholia, heart failure, hypertension, renal insufficiency, edema, obesity, bronchial asthma, gout, hyperuricemia, sudden infant death syndrome, immunosuppression, diabetes, myocardiac infection, thrombosis, obstruction, arteriosclerosis obliterans, thrombophlebitis, cerebral infarction, transient ischemic attack or angina pectoris, said compounds being of the formula ##STR1## wherein R.sup.1 is aryl, andR.sup.2 is unsaturated heterocyclic group which contains at least one heteroatom selected from the group consisting of N, O and S, which may have one or more suitable substituent(s),or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US5338743A
公开(公告)日:1994-08-16
申请号:US847286
申请日:1992-03-10
IPC分类号: A61K31/44 , A61K31/445 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/52 , A61K31/535 , A61K31/55 , C07D471/04 , C07D473/02 , A61K31/33 , A61K31/395 , A61K31/435 , A61K31/53 , A61K31/54
CPC分类号: C07D471/04 , A61K31/44 , A61K31/445 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/52 , A61K31/535 , A61K31/55 , C07D473/02
摘要: The present method for the treatment of pancreatitis, which comprises administering an effective amount of a pyrazolopyridine compound of the following formula: ##STR1## wherein R.sup.1 is lower alkyl, (substituted) aryl, or a heterocyclic group,R.sup.2 is a group of the formula ##STR2## wherein R.sup.4 is protected amino or hydroxy and R.sup.5 is hydrogen or lower alkyl; cyano; a group of the formula --A--R.sup.6, wherein R.sup.6 is an acyl group, and A is (halogenated) lower aliphatic hydrocarbon group; amidated carboxy; an unsaturated heterocyclic group; or (protected) amino; andR.sup.3 is hydrogen, lower alkyl, lower alkoxy or halogen; or a pharmaceutically acceptable salt thereof, to a human being having pancreatitis or an animal having pancreatitis in need thereof.
摘要翻译: 本发明的治疗胰腺炎的方法包括给予有效量的下式的吡唑并吡啶化合物:其中R1是低级烷基,(取代的)芳基或杂环基,R2是式 其中R 4是保护的氨基或羟基,R 5是氢或低级烷基; 氰基; 式-A-R6的基团,其中R6是酰基,A是(卤代)低级脂族烃基; 酰胺羧基; 不饱和杂环基; 或(保护)氨基; 并且R 3是氢,低级烷基,低级烷氧基或卤素; 或其药学上可接受的盐对具有胰腺炎的人或具有需要的胰腺炎的动物。
-
9.
公开(公告)号:US5102878A
公开(公告)日:1992-04-07
申请号:US495799
申请日:1990-03-19
IPC分类号: A61K31/435 , A61P7/02 , A61P7/10 , A61P9/04 , A61P9/12 , A61P13/02 , A61P15/00 , C07D471/04
CPC分类号: C07D471/04
摘要: The invention relates to a method for the treatment of ailments which comprises administering an effective amount of the pyrazolopyridine compounds of the invention.
-
公开(公告)号:US4673676A
公开(公告)日:1987-06-16
申请号:US669865
申请日:1984-11-09
申请人: Ikuo Ueda , Youichi Shiokawa , Takashi Manabe
发明人: Ikuo Ueda , Youichi Shiokawa , Takashi Manabe
IPC分类号: C07D487/04 , A61K31/4745 , A61K31/505 , A61P11/06 , C07D217/02 , C07D217/08 , C07D217/22 , C07D471/04
CPC分类号: C07D217/02 , C07D217/08 , C07D217/22 , C07D471/04
摘要: Pyrimidoisoquinoline/compounds of the formula: ##STR1## where R.sup.1 is H, halogen or lower alkyl, R.sup.2 is NH.sub.2, NO.sub.2 or acylamino and R.sup.3 is carboxy or protected carboxy, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof are disclosed in this application. Also disclosed is a method of treating allergies by administering the compounds of this invention.
摘要翻译: 嘧啶并喹啉/下式的化合物:其中R 1为H,卤素或低级烷基,R 2为NH 2,NO 2或酰基氨基,R 3为羧基或被保护的羧基,其药学上可接受的盐及其药物组合物在本申请中公开。 还公开了通过施用本发明化合物治疗过敏症的方法。
-
-
-
-
-
-
-
-
-